Cerner Deutschland GmbH Selected as New Member of Asklepios Future Hospital Program

CernerCerner Deutschland GmbH has joined the Asklepios Future Hospital Program (AFHP), which is administered by the Asklepios group, a leading hospital group in Europe. The AFHP is Europe's largest innovation platform in the information technology (IT) and medical device sectors and includes more than 25 industry partners. The goal of the program is to structure and streamline communication and data transfer in hospitals using state of the art technology. Cerner and the AFHP will strive to improve medical device infrastructure and create a solution for the centralized management of these devices. The collaboration aims to improve the maintenance process of healthcare devices, improve documentation quality and simplify clinician workflow. As a member of the program, Cerner will have the opportunity to pilot new solutions in live clinical settings and showcase them for patients and clinical staff, as well as interested visitors and potential German and international clients.

"The Asklepios Future Hospital Program emphasizes developing new mobile health and eHealth services and enhancing and optimizing clinical workflows. With Cerner, our alliance has gained a strong and competent new member to collectively develop innovative solutions for today’s healthcare challenges," said Uwe Pöttgen, CIO of the Asklepios group. "The goal of the AFHP is to increase communication and collaboration between all parties in an effort to positively shape our future healthcare system. We strongly believe Cerner will be a valuable contributor to this effort."

The Cerner CareAware iBus, which recently received its CE Marking certification from BSI on the basis of examination under Council Directive 93/42/EEC Annex II Section 3.2, was selected as Cerner's first pilot solution in the program. The Cerner CareAware iBus enables complete integration and management of medical devices across an entire organization. This increases patient safety by ensuring the right information is available at the right time within the electronic health record (EHR) and reducing the likelihood of data transcription errors. Connecting devices directly to the EHR automatically feeds the data gathered into the patient's record. Hospital efficiency is improved by requiring less time to review and input data from various devices, freeing clinicians to spend more time with patients at the bedside. In addition, optimized utilization significantly improves the device capacity. The hospital is enabled to improve compliance with their regulatory documentation requirements while saving time; yet the clinical advantage for patients, nurses and physicians remain the focal point.

"Cerner and the AFHP share a common vision of transforming healthcare to a model that revolves around the person," said Holger Cordes, general manager of Cerner Deutschland GmbH. "Innovation is the key to improving the quality and efficiency of healthcare. We are looking forward to working with the AFHP and its members to support this effort and to continue developing solutions that improve patient safety."

About Cerner Deutschland GmbH
Cerner is transforming healthcare by eliminating error, variance and waste for healthcare providers and consumers around the world. Cerner® solutions optimize processes for healthcare organizations ranging in size from single-doctor practices, to health systems, to entire countries, for the pharmaceutical and medical device industries, employer health and wellness services industry and for the healthcare commerce system. These solutions are licensed by approximately 9,000 facilities around the world, including more than 2,600 hospitals; 3,500 physician practices covering more than 30,000 physicians; 500 ambulatory facilities, such as laboratories, ambulatory centers, cardiac facilities, radiology clinics and surgery centers; 800 home health facilities; and 1,600 retail pharmacies. The trademarks, service marks and logos (collectively, the “Marks”) set forth herein are owned by Cerner Corporation and/or its subsidiaries in the United States and certain other countries throughout the world. Cerner Deutschland GmbH operates in two locations: Idstein near Wiesbaden in Hessia, and Herzogenrath near Aachen in North Rhine-Westphalia. Nasdaq: CERN. For more information about Cerner, please visit Cerner.de.

About Asklepios
Asklepios is one of the leading innovative international hospital chains. The group oversees over 110 facilities, about 60 day hospitals, 21,000 beds and more than 36,000 employees in Europe. Each year over one million patients trust Asklepios with their health. With these figures and a turnover of about 2.3 billion Euros, Asklepios is one of the largest private hospital chains in Germany and Europe.

Asklepios Future Hospital
Within the scope of the Asklepios Future Hospital program innovative technological solutions are developed and tested in collaboration with different industry partners. All approaches focus on ensuring a consistent, interoperable communication between all participants in the health care process; thus resulting in improved care quality of the patient, and also on the cost efficiency of these solutions. The AFH program together with its approximately 25 members from the industry is the largest European health care alliance of its kind. Its innovative solutions, which are implemented in a number of reference centers of the Asklepios hospitals, are some of the most important drivers of innovation in health care. The AFH program was conceived as an open and dynamic program.

Most Popular Now

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...

Bayer Acquires HiDoc Technologies and Ca…

Bayer is today announcing that it plans to acquire HiDoc Technologies GmbH in the first quarter of 2025 and to start commercialization of the digital health application, Cara Care®. Cara...

Almost All Leading AI Chatbots Show Sign…

Almost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas...